Drug profile · INN
simeprevir sodium
OLYSIO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
simeprevir sodium (OLYSIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN simeprevir sodium
Brand OLYSIO
Route ORAL
Formulation CAPSULE
Frequently asked questions
What is simeprevir sodium?
simeprevir sodium (OLYSIO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for simeprevir sodium?
OLYSIO is a marketed brand name for simeprevir sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of simeprevir sodium?
simeprevir sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.